Exact Mass: 527.1556
Exact Mass Matches: 527.1556
Found 320 metabolites which its exact mass value is equals to given mass value 527.1556
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Daunorubicin
Daunorubicin is only found in individuals that have used or taken this drug. It is a very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. [PubChem]Daunorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors KEIO_ID D106
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp
An O(4)-glycosyl-L-hydroxyproline that is cis-L-hydroxylproline glycosylated by a beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf moiety
Lumefantrine
Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
5-Carboxytetramethylrhodamine succinimidyl ester
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
2-(Dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
Esorubicin
D000970 - Antineoplastic Agents
N-Demethylmenogaril
Cerubidin
(2,6-epoxy-1,2alpha,3beta,4alpha,5alpha-pentahydroxy)hexane-(1->6)-5,6-dihydrochelerythrine|maclekarpine D
His Gln Glu Asp
Daunorubicin
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent A natural product found in Actinomadura roseola. D004791 - Enzyme Inhibitors
Cys Cys Phe Arg
Cys Cys Arg Phe
Cys Asp Lys Tyr
Cys Asp Gln Tyr
Cys Asp Tyr Lys
Cys Asp Tyr Gln
Cys Glu Asn Tyr
Cys Glu Tyr Asn
Cys Phe Cys Arg
Cys Phe Met Gln
Cys Phe Gln Met
Cys Phe Arg Cys
Cys Gly Trp Tyr
Cys Gly Tyr Trp
Cys Lys Asp Tyr
Cys Lys Tyr Asp
Cys Met Phe Gln
Cys Met Gln Phe
Cys Asn Glu Tyr
Cys Asn Tyr Glu
Cys Gln Asp Tyr
Cys Gln Phe Met
Cys Gln Met Phe
Cys Gln Tyr Asp
Cys Arg Cys Phe
Cys Arg Phe Cys
Cys Trp Gly Tyr
Cys Trp Tyr Gly
Cys Tyr Asp Lys
Cys Tyr Asp Gln
Cys Tyr Glu Asn
Cys Tyr Gly Trp
Cys Tyr Lys Asp
Cys Tyr Asn Glu
Cys Tyr Gln Asp
Cys Tyr Trp Gly
Asp Cys Lys Tyr
Asp Cys Gln Tyr
Asp Cys Tyr Lys
Asp Cys Tyr Gln
Asp Glu His Gln
Asp Glu Gln His
Asp His Glu Gln
Asp His Gln Glu
Asp Lys Cys Tyr
Asp Lys Tyr Cys
Asp Gln Cys Tyr
Asp Gln Glu His
Asp Gln His Glu
Asp Gln Tyr Cys
Asp Tyr Cys Lys
Asp Tyr Cys Gln
Asp Tyr Lys Cys
Asp Tyr Gln Cys
Glu Cys Asn Tyr
Glu Cys Tyr Asn
Glu Asp His Gln
Glu Asp Gln His
Glu Glu His Asn
Glu Glu Asn His
Glu His Asp Gln
Glu His Glu Asn
Glu His Asn Glu
Glu His Gln Asp
Glu Asn Cys Tyr
Glu Asn Glu His
Glu Asn His Glu
Glu Asn Tyr Cys
Glu Gln Asp His
Glu Gln His Asp
Glu Tyr Cys Asn
Glu Tyr Asn Cys
Phe Cys Cys Arg
Phe Cys Met Gln
Phe Cys Gln Met
Phe Cys Arg Cys
Phe Met Cys Gln
Phe Met Gln Cys
Phe Gln Cys Met
Phe Gln Met Cys
Phe Arg Cys Cys
Gly Cys Trp Tyr
Gly Cys Tyr Trp
Gly Trp Cys Tyr
Gly Trp Tyr Cys
Gly Tyr Cys Trp
Gly Tyr Trp Cys
His Asp Glu Gln
His Asp Gln Glu
His Glu Asp Gln
His Glu Glu Asn
His Glu Asn Glu
His Glu Gln Asp
His Asn Glu Glu
His Gln Asp Glu
Lys Cys Asp Tyr
Lys Cys Tyr Asp
Lys Asp Cys Tyr
Lys Asp Tyr Cys
Lys Tyr Cys Asp
Lys Tyr Asp Cys
Met Cys Phe Gln
Met Cys Gln Phe
Met Phe Cys Gln
Met Phe Gln Cys
Met Asn Thr Tyr
Met Asn Tyr Thr
Met Gln Cys Phe
Met Gln Phe Cys
Met Gln Ser Tyr
Met Gln Tyr Ser
Met Ser Gln Tyr
Met Ser Tyr Gln
Met Thr Asn Tyr
Met Thr Tyr Asn
Met Tyr Asn Thr
Met Tyr Gln Ser
Met Tyr Ser Gln
Met Tyr Thr Asn
Asn Cys Glu Tyr
Asn Cys Tyr Glu
Asn Glu Cys Tyr
Asn Glu Glu His
Asn Glu His Glu
Asn Glu Tyr Cys
Asn His Glu Glu
Asn Met Thr Tyr
Asn Met Tyr Thr
Asn Thr Met Tyr
Asn Thr Tyr Met
Asn Tyr Cys Glu
Asn Tyr Glu Cys
Asn Tyr Met Thr
Asn Tyr Thr Met
Gln Cys Asp Tyr
Gln Cys Phe Met
Gln Cys Met Phe
Gln Cys Tyr Asp
Gln Asp Cys Tyr
Gln Asp Glu His
Gln Asp His Glu
Gln Asp Tyr Cys
Gln Glu Asp His
Gln Glu His Asp
Gln Phe Cys Met
Gln Phe Met Cys
Gln His Asp Glu
Gln His Glu Asp
Gln Met Cys Phe
Gln Met Phe Cys
Gln Met Ser Tyr
Gln Met Tyr Ser
Gln Ser Met Tyr
Gln Ser Tyr Met
Gln Tyr Cys Asp
Gln Tyr Asp Cys
Gln Tyr Met Ser
Gln Tyr Ser Met
Arg Cys Cys Phe
Arg Cys Phe Cys
Arg Phe Cys Cys
Ser Met Gln Tyr
Ser Met Tyr Gln
Ser Gln Met Tyr
Ser Gln Tyr Met
Ser Tyr Met Gln
Ser Tyr Gln Met
Thr Met Asn Tyr
Thr Met Tyr Asn
Thr Asn Met Tyr
Thr Asn Tyr Met
Thr Tyr Met Asn
Thr Tyr Asn Met
Trp Cys Gly Tyr
Trp Cys Tyr Gly
Trp Gly Cys Tyr
Trp Gly Tyr Cys
Trp Tyr Cys Gly
Trp Tyr Gly Cys
Tyr Cys Asp Lys
Tyr Cys Asp Gln
Tyr Cys Glu Asn
Tyr Cys Gly Trp
Tyr Cys Lys Asp
Tyr Cys Asn Glu
Tyr Cys Gln Asp
Tyr Cys Trp Gly
Tyr Asp Cys Lys
Tyr Asp Cys Gln
Tyr Asp Lys Cys
Tyr Asp Gln Cys
Tyr Glu Cys Asn
Tyr Glu Asn Cys
Tyr Gly Cys Trp
Tyr Gly Trp Cys
Tyr Lys Cys Asp
Tyr Lys Asp Cys
Tyr Met Asn Thr
Tyr Met Gln Ser
Tyr Met Ser Gln
Tyr Met Thr Asn
Tyr Asn Cys Glu
Tyr Asn Glu Cys
Tyr Asn Met Thr
Tyr Asn Thr Met
Tyr Gln Cys Asp
Tyr Gln Asp Cys
Tyr Gln Met Ser
Tyr Gln Ser Met
Tyr Ser Met Gln
Tyr Ser Gln Met
Tyr Thr Met Asn
Tyr Thr Asn Met
Tyr Trp Cys Gly
Tyr Trp Gly Cys
Benflumetol
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Pirozadil
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent
[3,4,5-triacetyloxy-6-[(2-nitrophenyl)carbamothioylamino]oxan-2-yl]methyl acetate
Benzenepropanoic acid, 4-[[4-(4-methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-2-thiazolyl]methoxy]-2-methyl-
Barnidipine
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
5(6)-CARBOXYTETRAMETHYLRHODAMINE N-SUCCINIMIDYL ESTER
VT-1161
J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives C254 - Anti-Infective Agent > C514 - Antifungal Agent
Hydro-tris(3-phenylpyrazol-1-yl)borate potassium salt
5(6)-TAMRA, SE [5-(and-6)-Carboxytetramethylrhodamine, succinimidyl ester]
(R)-2-(3-(3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl)phenoxy)butanoic acid
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide
Lumefantrine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
2-(dibutylamino)-1-{2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethan-1-ol
(7S,9S)-9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(3-pyridinyl)-4-quinolinecarboxamide
[4-({3-[2-(1H-indol-3-yl)ethyl]-2-[(4-methoxyphenyl)imino]-4-oxo-1,3-thiazolidin-5-ylidene}methyl)phenoxy]acetic acid
(7R,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
2-[[4-(4-chlorophenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]thio]-N-(3-methoxyphenyl)-2-phenylacetamide
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
(2R,4S)-4-[[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]methyl]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-2-carboxylic acid
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
N3-[4-(difluoromethoxy)phenyl]-1-(3,4-dimethylphenyl)-N7-(2-hydroxyethyl)-2-mercaptoimidazo[1,2-a]pyridin-4-ium-3,7-dicarboxamide
9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp zwitterion
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp.
Beperidium iodide
Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
(1r,2z,6z,10e)-3-formyl-7,11-dimethylcyclododeca-2,6,10-trien-1-yl 6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate
aristoloterpenate i; 8-demethoxy
{"Ingredient_id": "HBIN016834","Ingredient_name": "aristoloterpenate i; 8-demethoxy","Alias": "NA","Ingredient_formula": "C31H29NO7","Ingredient_Smile": "NA","Ingredient_weight": "527.56","OB_score": "NA","CAS_id": "222403-62-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6648","PubChem_id": "NA","DrugBank_id": "NA"}
aristoloterpenate i; 8-demethoxy,2'e-isomer
{"Ingredient_id": "HBIN016835","Ingredient_name": "aristoloterpenate i; 8-demethoxy,2'e-isomer","Alias": "NA","Ingredient_formula": "C31H29NO7","Ingredient_Smile": "NA","Ingredient_weight": "527.56","OB_score": "NA","CAS_id": "222403-63-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6647","PubChem_id": "NA","DrugBank_id": "NA"}
aristophyllide a; 5',12'-diepimer,demethoxy
{"Ingredient_id": "HBIN016840","Ingredient_name": "aristophyllide a; 5',12'-diepimer,demethoxy","Alias": "NA","Ingredient_formula": "C31H29NO7","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6644","PubChem_id": "NA","DrugBank_id": "NA"}
aristophyllide a; demethoxy
{"Ingredient_id": "HBIN016841","Ingredient_name": "aristophyllide a; demethoxy","Alias": "NA","Ingredient_formula": "C31H29NO7","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6643","PubChem_id": "NA","DrugBank_id": "NA"}